STOCK TITAN

U S STEM CELL INC - $USRM STOCK NEWS

Welcome to our dedicated page for U S STEM CELL news (Ticker: $USRM), a resource for investors and traders seeking the latest updates and insights on U S STEM CELL stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect U S STEM CELL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of U S STEM CELL's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.9%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.16%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.24%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.71%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.51%
Tags
none
U S STEM CELL INC

OTC:USRM

USRM Rankings

USRM Stock Data

641
563.65M
10.95%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
Sunrise

About USRM

u.s. stem cell, inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. the company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its lead product adipocell™; physician training and certification; veterinary applications; stem cell banking; as well as creating and managing new stem cell clinics. in the past 20 years, to the company’s knowledge, u.s. stem cell, inc. has completed more clinical treatments than any other regenerative care provider in the world. with more than 700 physicians trained and certified with the company, u.s. stem cell, inc. boasts the largest network of physicians working together to continue its mission of harnessing the body’s own ability to heal from within to treat a wide variety of conditions and to improve quality of life.